Arrhythmias: IL-6 and Risk of Atrial Fibrillation in Chronic Kidney Disease

Overview

Journal Nat Rev Cardiol

Specialty Cardiology & Vascular Diseases

Date 2016 Feb 19

PMID 26888168

Citations 5

Authors

Gregory B Lim

Affiliations

Soon will be listed here.

Citing Articles

The association between systemic inflammation markers and paroxysmal atrial fibrillation.

Zhao X, Huang L, Hu J, Jin N, Hong J, Chen X BMC Cardiovasc Disord. 2024; 24(1):334.

PMID: 38961330 PMC: 11223271. DOI: 10.1186/s12872-024-04004-9.

Rivaroxaban Plasma Concentration and Clinical Outcomes on Older Patients with Non-valvular Atrial Fibrillation and Pulmonary Infection.

Yu Y, Li H, Liu J, Liang Q, Xie J, Sun G Am J Cardiovasc Drugs. 2023; 24(1):129-139.

PMID: 38142441 DOI: 10.1007/s40256-023-00622-4.

Potential Mechanism of Dingji Fumai Decoction Against Atrial Fibrillation Based on Network Pharmacology, Molecular Docking, and Experimental Verification Integration Strategy.

Liang Y, Liang B, Chen W, Wu X, Liu-Huo W, Zhao L Front Cardiovasc Med. 2021; 8:712398.

PMID: 34859062 PMC: 8631917. DOI: 10.3389/fcvm.2021.712398.

Correlation of the severity of chronic kidney disease with serum inflammation, osteoporosis and vitamin D deficiency.

Liu C, Li H Exp Ther Med. 2019; 17(1):368-372.

PMID: 30651805 PMC: 6307476. DOI: 10.3892/etm.2018.6916.

Association of asthma-chronic obstructive pulmonary disease overlap syndrome with coronary artery disease, cardiac dysrhythmia and heart failure: a population-based retrospective cohort study.

Yeh J, Wei Y, Lin C, Hsu W BMJ Open. 2017; 7(10):e017657.

PMID: 28982831 PMC: 5640024. DOI: 10.1136/bmjopen-2017-017657.

References

Amdur R, Mukherjee M, Go A, Barrows I, Ramezani A, Shoji J . Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study. PLoS One. 2016; 11(2):e0148189. PMC: 4739587. DOI: 10.1371/journal.pone.0148189. View